Naproxen

Download as doc, pdf, or txt
Download as doc, pdf, or txt
You are on page 1of 3

naproxen

(na prox' en)

naproxen
Apo-Naproxen (CAN), EC-Naprosyn, Naprelan, Naprosyn, Naxen (CAN),
Novo-Naprox (CAN)

naproxen sodium
Aleve, Anaprox, Anaprox DS, Apo-Napro-Na (CAN), Synflex (CAN)

Pregnancy Category B (first and second trimesters)


Pregnancy Category D (third trimester)

Drug classes
NSAID
Analgesic (nonopioid)

Therapeutic actions
Analgesic, anti-inflammatory, and antipyretic activities largely related to inhibition of
prostaglandin synthesis; exact mechanisms of action are not known.

Indications
• Mild to moderate pain
• Treatment of primary dysmenorrhea, rheumatoid arthritis, osteoarthritis,
ankylosing spondylitis, tendinitis, bursitis, acute gout
• OTC use: Temporary relief of minor aches and pains associated with the common
cold, headache, toothache, muscular aches, backache, minor pain of arthritis, pain
of menstrual cramps, reduction of fever
• Naproxen only: Treatment of juvenile arthritis

Contraindications and cautions


• Contraindicated with allergy to naproxen, salicylates, other NSAIDs; pregnancy;
lactation.
• Use cautiously with asthma, chronic urticaria, CV dysfunction; hypertension; GI
bleeding; peptic ulcer; impaired hepatic or renal function.

Available forms
Tablets—250, 375, 500 mg; 220, 275, 500 mg (as naproxen sodium); DR tablets—375,
500 mg; CR tablets—375, 500 mg; suspension—125 mg/5 mL

Dosages
Do not exceed 1,500 mg/day (1,375 mg/day naproxen sodium).
ADULTS
• Rheumatoid arthritis or osteoarthritis, ankylosing spondylitis:
Delayed-release (EC-Naprosyn)
375–500 mg PO bid.
Controlled-release (Naprelan)
750–1,000 mg PO daily.
Naproxen sodium
275–550 mg bid PO. May increase to 1.65 g/day for a limited period.
• Acute gout:
Controlled-release (Naprelan)
1,000–1,500 mg PO daily.
Naproxen sodium
825 mg PO followed by 275 mg q 8 hr until the attack subsides.
• Mild to moderate pain:
Controlled-release (Naprelan)
1,000 mg PO daily.
Naproxen sodium
550 mg PO followed by 275 mg q 6–8 hr.
OTC
200 mg PO q 8–12 hr with a full glass of liquid while symptoms persist. Do not exceed
600 mg in 24 hr.
PEDIATRIC PATIENTS
• Juvenile arthritis:
Naproxen
10 mg/kg/day given in 2 divided doses.
Naproxen sodium
Safety and efficacy not established.
OTC
Do not give to children < 12 yr unless under advice of physician.
GERIATRIC PATIENTS
Do not take > 200 mg q 12 hr PO.

Pharmacokinetics
Drug Onset Peak Duration
Naproxen 1 hr 2–4 hr < 7 hr
Naproxen sodium 1 hr 1–2 hr < 7 hr

Metabolism: Hepatic; T1/2: 12–15 hr


Distribution: Crosses placenta; enters breast milk
Excretion: Urine

Adverse effects
• CNS: Headache, dizziness, somnolence, insomnia, fatigue, tiredness, dizziness,
tinnitus, ophthalmic effects
• Dermatologic: Rash, pruritus, sweating, dry mucous membranes, stomatitis
• GI: Nausea, dyspepsia, GI pain, diarrhea, vomiting, constipation, flatulence
• GU: Dysuria, renal impairment, including renal failure, interstitial nephritis,
hematuria
• Hematologic: Bleeding, platelet inhibition with higher doses, neutropenia,
eosinophilia, leukopenia, pancytopenia, thrombocytopenia, agranulocytosis,
granulocytopenia, aplastic anemia, decreased Hgb or Hct, bone marrow
depression, menorrhagia
• Respiratory: Dyspnea, hemoptysis, pharyngitis, bronchospasm, rhinitis
• Other: Peripheral edema, anaphylactoid reactions to anaphylactic shock

Interactions
Drug-drug
• Increased serum lithium levels and risk of toxicity with naproxen
Drug-lab test
• Falsely increased values for urinary 17-ketogenic steroids; discontinue naproxen
therapy for 72 hr before adrenal function tests
• Inaccurate measurement of urinary 5-hydroxyindoleacetic acid

Nursing considerations
Assessment
• History: Allergy to naproxen, salicylates, other NSAIDs; asthma, chronic
urticaria, CV dysfunction; hypertension; GI bleeding; peptic ulcer; impaired
hepatic or renal function; pregnancy; lactation
• Physical: Skin color and lesions; orientation, reflexes, ophthalmologic and
audiometric evaluation, peripheral sensation; P, edema; R, adventitious sounds;
liver evaluation; CBC, clotting times, renal and liver function tests; serum
electrolytes; stool guaiac

Interventions
• Give with food or after meals if GI upset occurs.
• Arrange for periodic ophthalmologic examination during long-term therapy.
• If overdose occurs, institute emergency procedures—gastric lavage, induction of
emesis, supportive therapy.

Teaching points
• Take drug with food or meals if GI upset occurs; take only the prescribed dosage.
• Dizziness, drowsiness can occur (avoid driving or the use of dangerous
machinery).
• Report sore throat; fever; rash; itching; weight gain; swelling in ankles or fingers;
changes in vision; black, tarry stools.

Adverse effects in Italic are most common; those in Bold are life-threatening.

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy